Pfizer’s Rathbun “seconded” To SAFE-BioPharma
Executive Summary
George Rathbun will continue as Pfizer's global research development informatics director as he assumes the additional position of SAFE-BioPharma Association chief technology officer. "Pfizer has seconded Rathbun to SAFE-BioPharma," the industry-sponsored organization says in a Nov. 17 release. Rathbun, who will take over the new position immediately, will oversee and manage all aspects of technology for the organization, which is responsible for developing and managing secure digital signature standards (1"The Pink Sheet" July 11, 2005, p. 25)...
You may also be interested in...
Rx Industry E-Signature Standard Will Be Used In NCI Clinical Trials In 2006
A digital signature standard developed by the pharmaceutical industry will be ready for use in National Cancer Institute studies by 2006
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.